Fredun Pharma

74
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
1,685.75
-0.55 (-0.03%)
BSENSE

Mar 24

BSE+NSE Vol: 10.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023

Compare Profit and Loss Results of Fredun Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
430.00
-82.00
-19.07%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
430.00
-82.00
-19.07%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
-7.00
-15.00
-214.29%
Raw Materials Consumed
282.00
146.00
136.00
93.15%
Power & Fuel Cost
4.00
27.00
-23.00
-85.19%
Employee Cost
12.00
60.00
-48.00
-80.00%
Operating Expenses
10.00
57.00
-47.00
-82.46%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
13.00
-8.00
-61.54%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
8.00
-7.00
-87.50%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
329.00
-19.00
-5.78%
Operating Profit (PBDIT) excl Other Income
37.00
100.00
-63.00
-63.00%
Other Income
0.00
11.00
-11.00
-100.00%
Operating Profit (PBDIT)
38.00
112.00
-74.00
-66.07%
Interest
13.00
14.00
-1.00
-7.14%
Profit before Depriciation and Tax
25.00
97.00
-72.00
-74.23%
Depreciation
3.00
23.00
-20.00
-86.96%
Profit Before Taxation & Exceptional Items
21.00
74.00
-53.00
-71.62%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
74.00
-53.00
-71.62%
Provision for Tax
5.00
6.00
-1.00
-16.67%
Profit After Tax
15.00
67.00
-52.00
-77.61%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
276.00
-248.00
-89.86%
Profit Available for appropriations
44.00
344.00
-300.00
-87.21%
Appropriations
44.00
344.00
-300.00
-87.21%
Equity Dividend (%)
7%
50%
-43.00
Earnings Per Share
33.66
23.18
10.48
45.21%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023